Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II

PHASE1RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

Cannabis

Interventions

DRUG

Inhaled THC

4 mg inhaled THC

DRUG

Placebo

Inhaled placebo (no active cannabinoids)

Trial Locations (1)

RECRUITING

Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven

All Listed Sponsors

lead

Yale University

OTHER